Kim Chan-hyuk
Published 2022.07.04
With the U.S. Supreme Court’s overturn of Roe V. Wade ending the constitutional right to abortion on June 24, attention is on how the ruling will impact prescriptions of abortion-inducing medications.
Roe v. Wade was a landmark decision by the U.S. Supreme Court in 1973 that recognized women’s “right to privacy” in the Fourteenth Amendment, which protected a pregnant woman’s right to an abortion until the fetus can survive on its own outside the womb.
Continued: http://www.koreabiomed.com/news/articleView.html?idxno=14052